Cas:648895-46-9 1-(4-fluoro-benzoyl)-piperidin-4-one manufacturer & supplier

We serve Chemical Name:1-(4-fluoro-benzoyl)-piperidin-4-one CAS:648895-46-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-(4-fluoro-benzoyl)-piperidin-4-one

Chemical Name:1-(4-fluoro-benzoyl)-piperidin-4-one
CAS.NO:648895-46-9
Synonyms:1-(4-fluorobenzoyl)tetrahydro-4(1h)-pyridinone
Molecular Formula:C12H12FNO2
Molecular Weight:221.22800
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:37.38000
Exact Mass:221.08500
LogP:1.56870

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-(4-fluorobenzoyl)tetrahydro-4(1h)-pyridinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-fluorobenzoyl)tetrahydro-4(1h)-pyridinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-fluorobenzoyl)tetrahydro-4(1h)-pyridinone Use and application,1-(4-fluorobenzoyl)tetrahydro-4(1h)-pyridinone technical grade,usp/ep/jp grade.


Related News: An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally. 1-(4-fluoro-benzoyl)-piperidin-4-one manufacturer Both patients were being treated in isolation units at a Manila hospital. 1-(4-fluoro-benzoyl)-piperidin-4-one supplier An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally. 1-(4-fluoro-benzoyl)-piperidin-4-one vendor They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients. 1-(4-fluoro-benzoyl)-piperidin-4-one factory Both patients were being treated in isolation units at a Manila hospital.